User Tools

Site Tools


Guidelines for antithrombotic therapy for the treatment of venous thromboembolism (VTE), developed in 2001 by the Sixth American College of Chest Physicians (ACCP), state that patients with acute VTE should be treated with low molecular weight heparin, unfractionated intravenous heparin, or adjusted-dose subcutaneous heparin

american_college_of_chest_physicians.txt · Last modified: 2016/06/21 12:30 (external edit)